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Rationing Lung Transplants — Procedural Fairness  
in Allocation and Appeals
Keren Ladin, Ph.D., and Douglas W. Hanto, M.D., Ph.D.
Organ transplantation requires explicit rationing and relies 
on public trust and altruism to 
sustain the organ supply. The 
well-publicized cases of two pedi-
atric candidates for lung trans-
plants have shaken the trans-
plant community with emergency 
legal injunctions arguing that 
current lung-allocation policy is 
“arbitrary and capricious.” Al-
though the resulting transplan-
tation seemingly provided an up-
lifting conclusion to an emotional 
public debate, this precedent may 
open the floodgates to litigation 
from patients seeking to improve 
their chances of obtaining or-
gans. These cases questioned the 
potential disadvantaging of chil-
dren and the procedural fairness 
in lung allocation. But legal ap-
peals exacerbate inequities and 
undercut public trust in the or-
gan-transplantation system.
The controversy began when 
the parents of Sarah Murnaghan, 
a critically ill 10-year-old awaiting 
a lung transplant for cystic fibro-
sis, appealed through her physi-
cians to the Organ Procurement 
and Transplantation Network 
(OPTN) for an exception to the 
policy that restricts lung-trans-
plant candidates younger than 
12 years to receiving organs from 
donors younger than 12. When 
this appeal failed, the Murnaghans 
appealed to the media, politicians, 
and finally a federal judge to grant 
access to the larger pool of lungs 
from adult donors. They argued 
that mistreatment of pediatric 
candidates for transplants would 
probably result in Sarah’s death. 
The merits of the case were never 
argued, since during the 10-day 
temporary injunction, Murnaghan 
received two lung transplants 
from adult donors. She has had 
serious complications, including 
pneumonia, and required a trache-
ostomy.
In 2005, to improve equity and 
efficiency, the OPTN switched 
from prioritization based on wait-
ing time, a first-come–first-served 
approach that often prioritized 
less-urgent cases for organs, to 
an approach that incorporated 
consideration of urgency. After a 
5-year review, the OPTN had de-
veloped a lung allocation score 
(LAS) using medical factors that 
predict disease severity and the 
likelihood of dying on the wait-
ing list.1 Such scores were as-
signed only to patients 12 or older, 
because there were insufficient 
data to support their applicabil-
ity to younger populations, owing 
to their different diagnoses and 
limited outcomes data. Thus, pa-
tients younger than 12 were ex-
cluded from consideration for ad-
olescent and adult donors’ lungs 
(which are allocated according to 
the LAS and geography) and lim-
ited to use of pediatric donors’ 
lungs, which are allocated accord-
ing to two priority levels (differ-
ent degrees of urgency based on 
medical criteria) and geography.
The LAS policy has increased 
lung-transplantation rates and 
reduced mortality on the wait-
ing list among older patients.2 
Pediatric patients, however, con-
tinue to have higher waiting-list 
mortality and are less likely to 
receive transplants (see graphs), 
despite wider geographic shar-
ing of pediatric organs and the 
use of urgency levels — primar-
ily because there are few pediat-
ric donors. The supporters of 
the “under-12 rule” argue that it 
promotes equity and efficiency 
because of its aggregate bene-
fits. They also cite the problem-
atic discrepancy in lung size be-
tween adult donors and pediatric 
recipients. Furthermore, as a 
treatment for cystic fibrosis (the 
most common diagnosis among 
pediatric candidates for lung 
transplants), transplantation has 
been shown in several retrospec-
tive studies to have only mar-
ginal benefit, owing to improve-
ments in medical management 
(although some data suggest other-
wise).3 Lung transplantation in 
pediatric patients is also associ-
ated with high postoperative 
morbidity and mortality, largely 
because of the recipients’ under-
lying diagnoses.
Nevertheless, appeals to list 
children for adult organs have 
merit. First, designating age 12 
as the cutoff arbitrarily disad-
vantages some children because 
age is a poor proxy for size. 
Younger patients who meet the 
size requirements and could 
benefit from adult lungs should 
be considered eligible. Second, 
in allocating other organs, we 
often prioritize children, partly 
on the basis of “fair innings” 
considerations (equalizing peo-
ple’s chances of living until a 
given age) and partly because of 
the unique importance for physi-
cal and cognitive development that 
a transplant may confer. These 
arguments also apply to lung 
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transplantation. Third, transplant-
ing lungs into children is similar-
ly efficient to doing so in adults, 
since their graft-survival rates are 
similar. Lobar resection can facili-
tate transplantation of adult lungs 
into smaller pediatric patients — 
also with similar results.4 Finally, 
given the scarcity of pediatric 
lung transplants, the data neces-
sary for optimal validation of the 
LAS in this population may never 
be available. Without conclusive 
data, we should err on the side 
of inclusion, not exclusion from 
access to a broader supply of 
lifesaving organs. Currently, only 
30 children in the United States 
await lung transplants, and only 
11 of them are 6 to 11 years of 
age. The change that would oc-
cur by allowing these children 
access would most likely have 
little effect on nonpediatric can-
didates.
In response to objections that 
children are unfairly disadvan-
taged, the OPTN will review its 
lung-allocation policy during the 
next year and allow expedited ap-
peals to an expert lung-allocation 
board in the interim. Candidates 
approved during this period will 
gain access to the full pool of 
lungs on the basis of the LAS and 
geographic location, while main-
taining their pediatric priority.
Are the organ-allocation and 
appeals processes fair? Despite 
this case, we believe they are. An 
ethical framework that is gaining 
traction in health policy, Account-
ability for Reasonableness (A4R), 
offers an approach for achieving 
fairness and legitimacy in allo-
cating health resources.5 A4R 
requires transparency about the 
objectives of and evidence for de-
cisions, consensus about the rele-
vance of rationales used in re-
source allocation, a process for 
reevaluating and revising criteria 
in light of new evidence, and pro-
cedures for enforcing these condi-
tions in the deliberative process. 
This approach claims that a fair 
deliberative process results in out-
comes that are acceptable to all.
A4R has limitations in Mur-
naghan’s case, including those 
resulting from the limited data re-
garding lung-transplantation out-
comes in the pediatric population. 
But generally, organ allocation 
follows A4R’s tenets: it is public, 
transparent, revisable, enforce-
able, and open to appeals, and it 
incorporates key stakeholders. 
Organ-allocation algorithms seek 
to balance equity and efficiency. 
Committees comprising medical 
and ethics experts, transplant re-
cipients and donors, and other 
key stakeholders meet in a pre-
dictable and transparent way. 
They deliberate and issue reports 
and policy recommendations that 
are opened to public comment. 
Policies are enforced and revised 
regularly on the basis of new evi-
dence.
Transplant candidates and their 
families go to great lengths to 
obtain lifesaving treatment. They 
should be assured of fair process 
and, in cases of error or newly 
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Unadjusted Relative Risk of Dying While on the Waiting List or Becoming Too Sick to Receive a Lung Transplant (Panel A) and 
Relative Likelihood of Receiving a Lung Transplant (Panel B), According to Age Group, September 12, 2010 to March 11, 2013.
The vertical lines represent 95% confidence intervals. Ages are patients’ maximum age at listing or their age at the start of the 
period. Data are from the Lung Allocation Policy Review from the Executive Committee of the Organ Procurement and Transplan-
tation Network–United Network for Organ Sharing, June 10, 2013.
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appeal decisions. Appeals waged 
through federal courts and the 
court of public opinion, however, 
undermine fairness. Judicial ap-
peals grant discretionary access 
to wealthier people, exacerbating 
disparities and discrimination. 
Moreover, appeals are inefficient, 
complicating allocation and lead-
ing to longer allocation times, 
poorer matches due to expansion 
of criteria, and greater difficulty 
in managing the waiting list. 
Lawsuits also inappropriately sad-
dle courts with decisions about 
health policy. Finally, appeals re-
duce transparency and predictabil-
ity, undermining the public per-
ception of fairness, which could 
reduce donation rates.
Although the OPTN’s allow-
ance of appeals to an expert panel 
is preferable to judicial appeals, it 
is problematic. Relying on physi-
cians to appeal on behalf of can-
didates leaves patients of lower 
socioeconomic status, those less 
informed about their options, and 
those lacking advocates vulnera-
ble to worse treatment. Physicians 
may also fear that accepting the 
responsibility of mounting ap-
peals means assuming greater 
risk of poor outcomes and subse-
quent audits, which may also re-
sult in disparities.
To prevent unequal treatment, 
absent better data, we believe the 
OPTN should expand its policy 
to automatically assign an LAS to 
pediatric candidates and put 
those meeting the size and LAS 
criteria for adult and adolescent 
organs on the waiting list. Lung 
transplants should be allocated 
on the basis of the LAS and size 
match, with consideration of lo-
bar resection for small recipients 
of adult lungs. Children should 
retain preference for lungs from 
pediatric donors.
Overall, we believe that the 
organ-allocation process is fun-
damentally fair, in part because 
of procedures in place to revise 
and modify allocation. It is be-
cause of this fair process that er-
rors can be discovered and ad-
dressed. Our proposed changes 
would provide more lifesaving 
lungs to children; they would 
also provide useful data for the 
1-year policy review and could 
ensure equal treatment for all 
children awaiting lung trans-
plants.
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